Hostname: page-component-89b8bd64d-b5k59 Total loading time: 0 Render date: 2026-05-11T06:28:10.259Z Has data issue: false hasContentIssue false

Solution-based biophysical characterization of conformation change in structure-switching aptamers

Published online by Cambridge University Press:  03 September 2024

Sophie R. Eisen
Affiliation:
Department of Chemistry, York University, Toronto, ON, Canada
Philippe Dauphin-Ducharme
Affiliation:
Département de chimie, Université de Sherbrooke, Sherbrooke, QC, Canada
Philip E. Johnson*
Affiliation:
Department of Chemistry, York University, Toronto, ON, Canada
*
Corresponding author: Philip E. Johnson; Email: pjohnson@yorku.ca
Rights & Permissions [Opens in a new window]

Abstract

Structure-switching aptamers have become ubiquitous in several applications, notably in analytical devices such as biosensors, due to their ease of supporting strong signaling. Aside from their ability to bind specifically with their respective target, this class of aptamers also undergoes a conformational rearrangement upon target recognition. While several well-studied and early-developed aptamers (e.g., cocaine, ATP, and thrombin) have been found to have this structure-switching property, the vast majority do not. As a result, it is common to try to engineer aptamers into switches. This proves challenging in part because of the difficulty in obtaining structural and functional information about aptamers. In response, we review various readily available biophysical characterization tools that are capable of assessing structure switching of aptamers. In doing so, we delve into the fundamentals of these different techniques and detail how they have been utilized in characterizing structure-switching aptamers. While each of these biophysical techniques alone has utility, their real power to demonstrate the occurrence of structural change with ligand binding is when multiple techniques are used. We hope that through a deeper understanding of these techniques, researchers will be better able to acquire biophysical information about their aptamer–ligand systems and accelerate the translation of aptamers into biosensors.

Information

Type
Review
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press
Figure 0

Figure 1. Different types of aptamer conformational changes induced by ligand binding. (a) Three-way junction formation. (b) G-quadruplex formation. (c) Reduction in internal loop size. (d) Assembly of split aptamer strands.

Figure 1

Figure 2. Cocaine binding by MN19 and MN4 cocaine-binding aptamers monitored by 1D 1H NMR. The region of the NMR spectra shown focuses on the imino resonances. (a) Spectra of the MN19 cocaine-binding aptamer titrated with cocaine. (b) Spectra of the MN4 cocaine-binding aptamer titrated with cocaine. The NMR spectra of the MN19 aptamer demonstrates structural change with ligand binding by the appearance of new imino peaks for G29 (blue dot), G30 (orange dot), G31 (green dot), and T32 (red dot) that are not observed in the free spectrum. The NMR spectra of the prefolded MN4 aptamer shows chemical shift changes in imino peaks for G31 (green dot) and T32 (red dot) but not the appearance of new peaks. Spectra were acquired at 1.6 mM for MN19 and 1.0 mM for MN4 at 5°C in 5 mM KHPO4, 245 mM KCl (pH 6.8) and 90% H2O/10% 2H2O. The molar ratios of aptamer to cocaine are indicated.

Figure 2

Table 1. ITC-derived heat capacity changes (ΔCp) of aptamer–ligand binding interactions

Figure 3

Figure 3. Example of UV thermal melt curves of an aptamer that undergoes ligand-induced folding. UV thermal melt curve of an unfolded free aptamer shown by the dashed line. UV thermal melt curve of a folded ligand-bound aptamer shown by the solid line.

Figure 4

Figure 4. Fluorescent turn-on aptamer beacon. Structural change of aptamer with ligand binding results in an increase in fluorescent output (i.e., fluorescence de-quenching) by separating its fluorophore and quencher-labeled ends (complementary nucleotides added to the 5′ end of the thrombin-binding aptamer are shown in red) (Hamaguchi et al., 2001).

Figure 5

Figure 5. Fluorescent turn-off aptamer beacon. Conformational change of aptamer with ligand binding results in a decrease in fluorescent output (i.e., fluorescence quenching) by bringing together its fluorophore and quencher-labeled ends (Li et al., 2002).

Figure 6

Figure 6. FRET-based aptamer beacon. Structural change of aptamer with ligand binding produces an increase in FRET signal by bringing together its donor and acceptor-labeled ends (Li et al., 2008).

Figure 7

Figure 7. Fluorescent signaling aptamer using strand displacement. Ligand binding to aptamer labeled with fluorophore (FDNA) disrupts hybridization to a complementary strand labeled with quencher (QDNA) and results in an increase in fluorescence. A scheme similar to the one illustrated has been used with the ATP binding DNA aptamer (Nutiu and Li, 2003).

Figure 8

Figure 8. Split aptamer fluorescent sensor. Assembly of split aptamer fragments upon ligand binding results in a decrease in fluorescent output by bringing together their fluorophore and quencher-labeled ends. This scheme is adapted from one used for the cocaine-binding aptamer (Stojanovic et al., 2000).

Figure 9

Table 2. Summary of biophysical methods to demonstrate structure-switching binding mechanism of aptamers